These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8794007)

  • 21. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers.
    Ling M; Kanayama M; Roden R; Wu TC
    J Biomed Sci; 2000; 7(5):341-56. PubMed ID: 10971133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunobiology of papillomavirus infections.
    Stanley MA
    J Reprod Immunol; 2001; 52(1-2):45-59. PubMed ID: 11600177
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion].
    Riethmuller D; Seilles E
    J Gynecol Obstet Biol Reprod (Paris); 2000 Dec; 29(8):729-740. PubMed ID: 11139708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunology of anogenital human papillomavirus (HPV) infection.
    Tindle RW; Frazer IH
    Aust N Z J Obstet Gynaecol; 1990 Nov; 30(4):370-5. PubMed ID: 1964551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the immune system in anogenital human papillomavirus.
    Frazer IH
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection.
    Nicholls PK; Klaunberg BA; Moore RA; Santos EB; Parry NR; Gough GW; Stanley MA
    Virology; 1999 Dec; 265(2):365-74. PubMed ID: 10600607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue xenografts as a model system for study of the pathogenesis of papillomaviruses.
    Howett MK; Christensen ND; Kreider JW
    Clin Dermatol; 1997; 15(2):229-36. PubMed ID: 9167907
    [No Abstract]   [Full Text] [Related]  

  • 28. [Viruses and cervical cancers].
    Mathevet P
    Rev Prat; 2001 Sep; 51(13):1413-6. PubMed ID: 11601069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of mature dendritic cells for anti-human papillomavirus peptide-based vaccination in transplant patients.
    Mariat C; Alamartine E; Sabido O; Berthoux F
    Transplant Proc; 2002 Nov; 34(7):2836-7. PubMed ID: 12431627
    [No Abstract]   [Full Text] [Related]  

  • 30. The host response to lesions induced by human papillomavirus.
    Stanley M; Coleman N; Chambers M
    Ciba Found Symp; 1994; 187():21-32; discussion 32-44. PubMed ID: 7796671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of macrophages in papillomavirus infections].
    Bianchi A; Dachez R; Pollini G; Monsonego J; Alonso JM
    Pathol Biol (Paris); 1997 Feb; 45(2):165-8. PubMed ID: 9247039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune cellular response to HPV: current concepts.
    Gonçalves MA; Donadi EA
    Braz J Infect Dis; 2004 Feb; 8(1):1-9. PubMed ID: 15137933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic responses to human papillomavirus infection.
    Gissmann L
    Obstet Gynecol Clin North Am; 1996 Sep; 23(3):625-39. PubMed ID: 8869949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do manatees hold the key to understanding papillomaviruses?
    Kuehn BM
    J Am Vet Med Assoc; 2002 Nov; 221(9):1240-1. PubMed ID: 12418685
    [No Abstract]   [Full Text] [Related]  

  • 35. Commentary.
    Toy EP
    Reprod Sci; 2007 Dec; 14(8):736. PubMed ID: 18089591
    [No Abstract]   [Full Text] [Related]  

  • 36. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.
    Peng S; Frazer IH; Fernando GJ; Zhou J
    Virology; 1998 Jan; 240(1):147-57. PubMed ID: 9448699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular immunity in cutaneous and genital HPV infections.
    Malejczyk J; Majewski S; Jabłońska S
    Clin Dermatol; 1997; 15(2):261-74. PubMed ID: 9167910
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prospectives and issues of HPV vaccination in France].
    Denis F
    Med Mal Infect; 2005 Jun; 35 Suppl 2():S140. PubMed ID: 15978373
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18.
    Dias D; Van Doren J; Schlottmann S; Kelly S; Puchalski D; Ruiz W; Boerckel P; Kessler J; Antonello JM; Green T; Brown M; Smith J; Chirmule N; Barr E; Jansen KU; Esser MT
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):959-69. PubMed ID: 16085914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection.
    Schäfer K; Müller M; Faath S; Henn A; Osen W; Zentgraf H; Benner A; Gissmann L; Jochmus I
    Int J Cancer; 1999 Jun; 81(6):881-8. PubMed ID: 10362134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.